TBPH
Theravance Biopharma, Inc.
16.98
2 x 12.24
1 x 16.99
bid
ask
-
0.02
0.12%
2 @ 04:00 PM
17.00 +0.02 (0.12%)
| Ytd | -9.25% | |
| 1y | 55.64% |
16.96
day range
17.07
10.82
52 week range
21.03
| Open | 17.02 | Prev Close | 17.00 | Low | 16.96 | High | 17.07 | Mkt Cap | 880.04M |
| Vol | 1.30M | Avg Vol | 499.96K | EPS | 2.23 | P/E | 7.61 | Forward P/E | 163.17 |
| Beta | 0.25 | Short Ratio | 19.79 | Inst. Own | 96.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 16.58 | 200-d Avg | 16.77 | 1yr Est | 13.20 |
| Income Statement | |||
| Total Revenue | 17.70M | ||
| Revenues (USD) | 17.70M | ||
| Gross Profit | 17.70M | ||
| Operating Expenses | 27.18M | ||
| Research and Development Expense | 5.83M | ||
| Selling, General and Administrative Expense | 17.72M | ||
| Operating Income | -9.48M | ||
| Income Tax Expense | -1.54M | ||
| Net Income | -4.93M | ||
| Net Income Common Stock | -4.93M | ||
| Net Income Common Stock (USD) | -4.93M | ||
| Consolidated Income | -4.93M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -6.47M | ||
| Earning Before Interest & Taxes (USD) | -6.47M | ||
| Weighted Average Shares | 51.28M | ||
| Weighted Average Shares Diluted | 51.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 288.94M | ||
| Cash and Equivalents (USD) | 288.94M | ||
| Investments | 106.57M | ||
| Investments Current | 106.57M | ||
| Trade and Non-Trade Receivables | 15.58M | ||
| Current Assets | 417.63M | ||
| Property, Plant & Equipment Net | 28.54M | ||
| Total Assets | 472.31M | ||
| Debt Current | 10.75M | ||
| Total Debt | 40.50M | ||
| Current Liabilities | 31.78M | ||
| Debt Non-Current | 29.75M | ||
| Total Liabilities | 181.72M | ||
| Accumulated Retained Earnings (Deficit) | -864.56M | ||
| Accumulated Other Comprehensive Income | -62.00K | ||
| Shareholders Equity | 290.59M | ||
| Shareholders Equity (USD) | 290.59M | ||
| Assets Non-Current | 54.68M | ||
| Total Debt (USD) | 40.50M | ||
| Liabilities Non-Current | 149.94M | ||
| Trade and Non-Trade Payables | 1.10M | ||
| Tax Liabilities | 92.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.44M | ||
| Net Cash Flow from Financing | -5.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 120.30M | ||
| Issuance (Purchase) of Equity Shares | -5.58M | ||
| Net Cash Flow from Investing | 52.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 52.59M | ||
| Net Cash Flow from Operations | 73.28M | ||
| Share Based Compensation | 4.50M | ||